131 related articles for article (PubMed ID: 29877239)
1. [Adult acute lymphoblastic leukemia: update on pathophysiology and management].
Hayakawa F
Rinsho Ketsueki; 2018; 59(5):497-503. PubMed ID: 29877239
[TBL] [Abstract][Full Text] [Related]
2. Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia.
Liu YF; Wang BY; Zhang WN; Huang JY; Li BS; Zhang M; Jiang L; Li JF; Wang MJ; Dai YJ; Zhang ZG; Wang Q; Kong J; Chen B; Zhu YM; Weng XQ; Shen ZX; Li JM; Wang J; Yan XJ; Li Y; Liang YM; Liu L; Chen XQ; Zhang WG; Yan JS; Hu JD; Shen SH; Chen J; Gu LJ; Pei D; Li Y; Wu G; Zhou X; Ren RB; Cheng C; Yang JJ; Wang KK; Wang SY; Zhang J; Mi JQ; Pui CH; Tang JY; Chen Z; Chen SJ
EBioMedicine; 2016 Jun; 8():173-183. PubMed ID: 27428428
[TBL] [Abstract][Full Text] [Related]
3. Frequency and outcome of pediatric acute lymphoblastic leukemia with ZNF384 gene rearrangements including a novel translocation resulting in an ARID1B/ZNF384 gene fusion.
Shago M; Abla O; Hitzler J; Weitzman S; Abdelhaleem M
Pediatr Blood Cancer; 2016 Nov; 63(11):1915-21. PubMed ID: 27392123
[TBL] [Abstract][Full Text] [Related]
4. [Acute lymphoblastic leukemia of adolescents and young adults: from the viewpoint of physicians].
Yasuda T; Hayakawa F
Rinsho Ketsueki; 2017; 58(8):1031-1037. PubMed ID: 28883266
[TBL] [Abstract][Full Text] [Related]
5. [Clinical characteristics and outcomes of childhood B-ALL with ZNF384 and MEF2D rearrangements].
Hirabayashi S; Manabe A; Ohki K; Kiyokawa N
Rinsho Ketsueki; 2023; 64(7):633-638. PubMed ID: 37544723
[TBL] [Abstract][Full Text] [Related]
6. [B cell acute lymphoblastic leukemia therapy: an up to date overview].
Hayakawa F
Rinsho Ketsueki; 2021; 62(8):1094-1101. PubMed ID: 34497196
[TBL] [Abstract][Full Text] [Related]
7. [Acute leukemia in adolescents and young adults].
Tomizawa D
Rinsho Ketsueki; 2017; 58(10):2160-2167. PubMed ID: 28978861
[TBL] [Abstract][Full Text] [Related]
8. Detection of a Cryptic EP300/ZNF384 Gene Fusion by Chromosomal Microarray and Next-Generation Sequencing Studies in a Pediatric Patient with B-Lymphoblastic Leukemia.
Berg HE; Blackburn PR; Smadbeck JB; Swanson KE; Rice CS; Webley MR; Johnson SH; Vasmatzis G; Xu X; Greipp PT; Hoppman NL; Ketterling RP; Baughn LB; Boston CH; Sutton LM; Peterson JF
Lab Med; 2021 May; 52(3):297-302. PubMed ID: 33145596
[TBL] [Abstract][Full Text] [Related]
9. Transcriptome sequencing in pediatric acute lymphoblastic leukemia identifies fusion genes associated with distinct DNA methylation profiles.
Marincevic-Zuniga Y; Dahlberg J; Nilsson S; Raine A; Nystedt S; Lindqvist CM; Berglund EC; Abrahamsson J; Cavelier L; Forestier E; Heyman M; Lönnerholm G; Nordlund J; Syvänen AC
J Hematol Oncol; 2017 Aug; 10(1):148. PubMed ID: 28806978
[TBL] [Abstract][Full Text] [Related]
10. Identification of the TAF15-ZNF384 fusion gene in two new cases of acute lymphoblastic leukemia with a t(12;17)(p13;q12).
Nyquist KB; Thorsen J; Zeller B; Haaland A; Trøen G; Heim S; Micci F
Cancer Genet; 2011 Mar; 204(3):147-52. PubMed ID: 21504714
[TBL] [Abstract][Full Text] [Related]
11. Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP.
Qian M; Zhang H; Kham SK; Liu S; Jiang C; Zhao X; Lu Y; Goodings C; Lin TN; Zhang R; Moriyama T; Yin Z; Li Z; Quah TC; Ariffin H; Tan AM; Shen S; Bhojwani D; Hu S; Chen S; Zheng H; Pui CH; Yeoh AE; Yang JJ
Genome Res; 2017 Feb; 27(2):185-195. PubMed ID: 27903646
[TBL] [Abstract][Full Text] [Related]
12. Establishment and genetic characterization of a novel mixed-phenotype acute leukemia cell line with EP300-ZNF384 fusion.
Ping N; Qiu H; Wang Q; Dai H; Ruan C; Ehrentraut S; Drexler HG; MacLeod RA; Chen S
J Hematol Oncol; 2015 Aug; 8():100. PubMed ID: 26293203
[TBL] [Abstract][Full Text] [Related]
13. Management of acute lymphoblastic leukemia in young adults.
Muffly LS; Reizine N; Stock W
Clin Adv Hematol Oncol; 2018 Feb; 16(2):138-146. PubMed ID: 29741514
[TBL] [Abstract][Full Text] [Related]
14. Mixed Phenotype Acute Leukemia with t(12;17)(p13;q21)/TAF15-ZNF384 and Other Chromosome Abnormalities.
Yamamoto K; Kawamoto S; Mizutani Y; Yakushijin K; Yamashita T; Nakamachi Y; Kawano S; Hayashi Y; Matsuoka H; Minami H
Cytogenet Genome Res; 2016; 149(3):165-170. PubMed ID: 27607436
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy approaches to treat adult acute lymphoblastic leukemia.
Maino E; Bonifacio M; Scattolin AM; Bassan R
Expert Rev Hematol; 2016 Jun; 9(6):563-77. PubMed ID: 27011303
[TBL] [Abstract][Full Text] [Related]
16. Inotuzumab Ozogamicin: First Global Approval.
Lamb YN
Drugs; 2017 Sep; 77(14):1603-1610. PubMed ID: 28819740
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic evaluation of RNA sequencing for the detection of genetic abnormalities associated with Ph-like acute lymphoblastic leukemia (ALL).
Yap KL; Furtado LV; Kiyotani K; Curran E; Stock W; McNeer JL; Kadri S; Segal JP; Nakamura Y; Le Beau MM; Gurbuxani S; Raca G
Leuk Lymphoma; 2017 Apr; 58(4):950-958. PubMed ID: 27855558
[TBL] [Abstract][Full Text] [Related]
18. EP300-ZNF384 fusion gene product up-regulates GATA3 gene expression and induces hematopoietic stem cell gene expression signature in B-cell precursor acute lymphoblastic leukemia cells.
Yaguchi A; Ishibashi T; Terada K; Ueno-Yokohata H; Saito Y; Fujimura J; Shimizu T; Ohki K; Manabe A; Kiyokawa N
Int J Hematol; 2017 Aug; 106(2):269-281. PubMed ID: 28378055
[TBL] [Abstract][Full Text] [Related]
19. Inotuzumab ozogamicin in the treatment of acute lymphoblastic leukemia.
Dahl J; Marx K; Jabbour E
Expert Rev Hematol; 2016; 9(4):329-34. PubMed ID: 26783163
[TBL] [Abstract][Full Text] [Related]
20. A typical bedside-to-bench investigation of leukemogenic driver MEF2D fusion reveals new targeted therapy in B-cell acute lymphoblastic leukemia.
Zhang H; Meng G
Blood Sci; 2022 Jul; 4(3):161-163. PubMed ID: 36518591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
